Weiling He

5.0k total citations · 2 hit papers
94 papers, 3.7k citations indexed

About

Weiling He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weiling He has authored 94 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 29 papers in Cancer Research and 28 papers in Oncology. Recurrent topics in Weiling He's work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (11 papers) and Nanoplatforms for cancer theranostics (10 papers). Weiling He is often cited by papers focused on RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (11 papers) and Nanoplatforms for cancer theranostics (10 papers). Weiling He collaborates with scholars based in China, United States and South Korea. Weiling He's co-authors include Run Lin, Zunfu Ke, Yulong He, Guohui Wan, Yi Niu, Xianzhang Bu, Lei Sun, Arabella Wan, Heng Liang and Ziyou Lin and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Weiling He

90 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global liver disease burdens and research trends: Analysis from a Chinese perspective

2019 410 citations Weiling He et al. profile →
RNA m ⁶ A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy

2020 359 citations Ziyou Lin, Yi Niu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiling He China	31	1.9k	1.2k	877	557	473	94	3.7k
Yingqi Hua China	33	1.8k 0.9×	776 0.7×	827 0.9×	554 1.0×	654 1.4×	104	3.7k
Shengli Yang China	33	2.0k 1.1×	845 0.7×	1.0k 1.2×	480 0.9×	432 0.9×	167	4.0k
Qing Xu China	32	2.0k 1.0×	1.0k 0.9×	1.5k 1.7×	556 1.0×	876 1.9×	182	4.3k
Chang Zou China	33	2.1k 1.1×	1.1k 0.9×	997 1.1×	499 0.9×	547 1.2×	120	3.9k
Yi Zhu China	38	1.9k 1.0×	1.0k 0.9×	778 0.9×	468 0.8×	334 0.7×	144	3.6k
Chen Yang China	31	1.9k 1.0×	1.1k 0.9×	999 1.1×	474 0.9×	766 1.6×	153	3.5k
Zhengdong Cai China	28	1.4k 0.8×	628 0.5×	733 0.8×	505 0.9×	588 1.2×	91	2.9k
Wen Xu China	32	1.8k 1.0×	747 0.6×	1.1k 1.2×	351 0.6×	672 1.4×	157	4.2k
Xiaowei Qi China	33	1.9k 1.0×	1.3k 1.1×	835 1.0×	272 0.5×	425 0.9×	199	3.8k
Seema Singh United States	43	3.1k 1.7×	1.8k 1.5×	1.4k 1.6×	724 1.3×	380 0.8×	126	5.1k

Countries citing papers authored by Weiling He

Since Specialization

Citations

This map shows the geographic impact of Weiling He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiling He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiling He more than expected).

Fields of papers citing papers by Weiling He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiling He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiling He. The network helps show where Weiling He may publish in the future.

Co-authorship network of co-authors of Weiling He

This figure shows the co-authorship network connecting the top 25 collaborators of Weiling He. A scholar is included among the top collaborators of Weiling He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiling He. Weiling He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mei, Song, et al.. (2025). Beyond polarization: macrophage senescence in immunoregulation and cancer therapy. International Journal of Biological Sciences. 21(10). 4312–4333.

Ren, Xue, et al.. (2025). Circulating tumor cells: mechanisms and clinical significance in colorectal cancer metastasis. Molecular Cancer. 24(1). 242–242. 1 indexed citations

Qiu, Xingfeng, Jiale Qin, Xiang Zhang, et al.. (2025). Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes. Journal of Translational Medicine. 23(1). 175–175. 8 indexed citations

Li, Wenjuan, Guo-Sheng Hu, Jingjing Yang, et al.. (2025). Hypoxia-induced PRMT1 methylates HIF2β to promote breast tumorigenesis via enhancing glycolytic gene transcription. Cell Reports. 44(4). 115487–115487. 1 indexed citations

Su, Yanhong, Bing Liu, Binghan Wang, et al.. (2024). Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine. Small. 20(25). e2310342–e2310342. 29 indexed citations

Song, Mei, Shuting Huang, Ziyi Zhao, et al.. (2024). UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling. Redox Biology. 76. 103349–103349. 10 indexed citations

Chen, Lulu, et al.. (2024). Serotonin signalling in cancer: Emerging mechanisms and therapeutic opportunities. Clinical and Translational Medicine. 14(7). e1750–e1750. 23 indexed citations

Wei, Ran, Qian Yan, Chong Wu, et al.. (2024). Prognostic and predictive value of examined lymph node count in stage III colorectal cancer: a population based study. World Journal of Surgical Oncology. 22(1). 155–155. 1 indexed citations

Huang, Chunliu, Xuefei Wang, Yingzhao Wang, et al.. (2024). Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47. Nature Cancer. 5(3). 500–516. 44 indexed citations

10.

Liu, Bixia, Yuting Luo, Yanxia Wang, et al.. (2023). New insights into the correlations between circulating tumor cells and target organ metastasis. Signal Transduction and Targeted Therapy. 8(1). 465–465. 72 indexed citations

11.

Huang, Shuting, et al.. (2023). Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug. Redox Biology. 67. 102891–102891. 35 indexed citations

12.

Huang, Shuting, et al.. (2023). Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers. International Immunopharmacology. 122. 110602–110602. 16 indexed citations

13.

Du, Yawei, Jiancheng Zheng, Zhengwei Cai, et al.. (2023). Oral Administration of Multistage Albumin Nanomedicine Depots (MANDs) for Targeted Efficient Alleviation of Chronic Inflammatory Diseases. Advanced Functional Materials. 33(9). 30 indexed citations

14.

He, Weiling. (2023). Solar Maximum Power Point Tracking Algorithm Based on Wavelet Neural Network. Journal of Applied Data Sciences. 4(1). 30–37. 3 indexed citations

15.

Lin, Run, et al.. (2023). Thermosensitive selenium hydrogel boosts antitumor immune response for hepatocellular carcinoma chemoradiotherapy. Nano Today. 50. 101823–101823. 25 indexed citations

16.

Lin, Ziyou, Arabella Wan, Lei Sun, et al.. (2022). N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Molecular Therapy. 31(2). 517–534. 56 indexed citations

17.

Chen, Feng, Zhuojia Chen, Tao Guan, et al.. (2021). N6 -Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis. Cancer Research. 81(11). 2847–2860. 90 indexed citations

18.

Li, Qinghai, Weiling He, & Guohui Wan. (2021). Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers. Frontiers in Oncology. 10. 586789–586789. 15 indexed citations

19.

Lin, Run, Hui Zhang, Yujie Yuan, et al.. (2020). Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma. Cancer Immunology Research. 8(4). 479–492. 169 indexed citations

20.

He, Weiling. (2014). RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 andcis-diamminedichloroplatinum on gastric cancer. World Journal of Gastroenterology. 20(29). 10094–10094. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact